From February 6, 2024 to March 31, 2024, the company has repurchased 17,965,404 shares, representing 1.75% for CNY 84.23 million. With this, the company has completed the repurchase of 17,965,404 shares, representing 1.75% for CNY 84.23 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 CNY | +0.23% | -1.11% | -34.22% |
05-20 | Shanxi Zhendong Pharmaceutical Co.,Ltd Approves Board Appointments | CI |
05-06 | Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.22% | 630M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 300158 Stock
- News Shanxi Zhendong Pharmaceutical Co.,Ltd
- Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024.